The Transcriptional Response to Lung-Targeting Lipid Nanoparticles in Vivo

33Citations
Citations of this article
62Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Lipid nanoparticles (LNPs) have delivered RNA to hepatocytes in patients, underscoring the potential impact of nonliver delivery. Scientists can shift LNP tropism to the lung by adding cationic helper lipids; however, the biological response to these LNPs remains understudied. To evaluate the hypothesis that charged LNPs lead to differential cellular responses, we quantified how 137 LNPs delivered mRNA to 19 cell types in vivo. Consistent with previous studies, we observed helper lipid-dependent tropism. After identifying and individually characterizing three LNPs that targeted different tissues, we studied the in vivo transcriptomic response to these using single-cell RNA sequencing. Out of 835 potential pathways, 27 were upregulated in the lung, and of these 27, 19 were related to either RNA or protein metabolism. These data suggest that endogenous cellular RNA and protein machinery affects mRNA delivery to the lung in vivo.

Cite

CITATION STYLE

APA

Radmand, A., Lokugamage, M. P., Kim, H., Dobrowolski, C., Zenhausern, R., Loughrey, D., … Dahlman, J. E. (2023). The Transcriptional Response to Lung-Targeting Lipid Nanoparticles in Vivo. Nano Letters, 23(3), 993–1002. https://doi.org/10.1021/acs.nanolett.2c04479

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free